FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
Amgen acquired deCODE Genetics for $415 million
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
USDA scientists and cooperators sequence wheat genome
On Nov. 28, 2012, scientists from the USDA’s Agricultural Research Service (ARS), as part of an international team,…
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
Biotechnology | CDC | Infectious Disease | Life Science News | Neurology | Pharmaceutical | Therapeutics
The CDC responded to the large fungal meningitis outbreak
On Nov. 15, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to the fungal meningitis…
International team sequenced the bread wheat genome
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
ACIP voted to recommend use of HibMenCY vaccine in infants at increased risk for meningococcal disease
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
ACIP voted to recommend that pregnant women receive a dose of Tdap during each pregnancy
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
LigoCyte Pharmaceuticals was acquired Takeda Pharmaceutical
On Oct. 3, 2012, Takeda Pharmaceutical acquired LigoCyte for an upfront payment of $60 million, with future contingent…
Grateful family left more than $10 million to support OHSU
On Sept. 10, 2012, Oregon Health Science University (OHSU) announced the estate of Garthe and Grace Brown designated…
Biotechnology | Life Science News | Medicine | Non-Profit Research | Prehistory | Therapeutics | U.S. Congress
2012 Lasker awards honor scientists for groundbreaking medical research
On Sept. 10, 2012, the Albert and Mary Lasker Foundation announced winners of the annual Lasker Awards: Michael…
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
Human Genome Sciences was acquired by GlaxoSmithKline for $3.6 billion
On Aug. 3, 2012, GlaxoSmithKline announced that it had completed its acquisition of Human Genome Sciences for $3.6…
The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
Biotechnology | Diagnostics | Life Science News | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012 the University of Kansas Cancer Center earned National Cancer Institute designation. Through efforts initially…
The NIH awarded $65 million grant to Institute for Translational Health Sciences to turn promising discoveries into patient care advances
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
The Serum Institute of India acquired Bilthoven Biologicals from The Netherlands Government
On Jul. 4, 2012, the Serum Institute of India made its first International acquisition by acquiring Bilthoven Biologicals,…
Roche announced the closure of the Nutley/Clifton campus
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
The CDC responded to a multi-state outbreak of salmonella infections associated with raw tuna
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) responded to a multi-state outbreak…
ACIP expanded PCV13 immunization recommendations
On Jun. 26, 2012, the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices…
The Helix Center Biotech Incubator opened its doors
On Jun. 25, 2012, the Helix Center Biotech Incubator opened its doors, owned and operated by the St….
Rocky Mountain Biological Laboratory announced $10 million legacy campaign
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
Biotechnology | Disease | FDA | Life Science News | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
The European Region of the world was certified as polio-free
On Jun. 21, 2012, the European Region of the world was certified as polio-free. Certification followed years of…
Oxford University researchers dated relics as first century AD
On Jun. 15, 2012, Oxford University researchers announced that a knucklebone claimed to be of John the Baptist…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
The Human Microbiome Project milestone announced
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….